Skip to main content
. 2018 Jan 8;8:58. doi: 10.1038/s41598-017-18255-4

Table 6.

Adverse events (eyes [%]).

Systemic events
Any APTC ATEs 0 (0)
Vasucular death 0 (0)
Nonfatal myocardial infarction 0 (0)
Nonfatal stroke 0 (0)
Venous thromboembolic events 0 (0)
Congestive heart failure 0 (0)
Ocular events
Endophthalmitis 0 (0)
Retinal detachment 0 (0)
RPE tears 0 (0)
Submacular hemorrhage 0 (0)
Uveitis 0 (0)
Epiphora 1 (3)

APTC ATE, Antiplatelet Trialists’ Collaboration arterial thromboembolic events; RPE, retinal pigment epithelium.